CureDM is a biopharmaceutical company established to develop new therapies that may prevent, ameliorate or reverse diabetes and allow for the discontinuation of insulin.
|
|
|
|
|
1-10 employees
View all CureDM employees
|
|
|
Biotechnology Research
|
|
|
610-645-6796
|
|
|
Wilmington, Delaware
|
|
|
2004
|
The decision makers in CureDM are Donna Morrow, etc. Click to Find CureDM decision makers emails.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.